Highlights Renovaro Inc.

Equities

RENB

US29350E1047

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
1.13 ^USD	-5.83%		-24.67%	-64.35%

04-24	Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	MT
04-18	Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	04-24	MT
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-14	CI
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics	02-13	MT
Renovaro Shares Tumble Following Report From Short-Seller Hindenburg	02-13	MT
Renovaro Biosciences Inc. completed the acquisition of GEDi Cube Intl Ltd.	02-12	CI
Renovaro Biosciences' Shareholders Approve Share Issuance for Merger Deal With GEDi Cube	01-25	MT
Renovaro Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Renovaro Biosciences Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	02/10/23	CI
Renovaro Biosciences, GEDi Cube Enter Stock-for-stock Acquisition Deal	29/09/23	MT
Renovaro BioSciences Signs Letter of Intent to Merge With GEDi Cube; Shares Rise	09/08/23	MT
Renovaro Biosciences Inc. signed a letter-of-intent to acquire GEDi Cube Intl Ltd.	08/08/23	CI
Enochian Biosciences Inc. Announces That Its Cancer Platform Remains on Track for Trials in Humans Following FDA Review	08/06/23	CI
Enochian Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	12/05/23	CI
Enochian Biosciences Inc. Announces Scientific Presentation of Proof-of-Concept Studies for Potential Therapy for Cancers with a Poor Life Expectancy	29/03/23	CI
Enochian Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	09/03/23	CI
Enochian Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	07/03/23	CI
Enochian Biosciences, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	27/02/23	CI
COLUMN-Adani Group threatens, but Hindenburg Research rarely sued in U.S	02/02/23	RE
Enochian Biosciences, Inc. Announces Findings from A Rigorous Internal Review of Scientific Data	01/07/22	CI
Enochian Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	13/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Renovaro Inc.

Equities

RENB

US29350E1047

Highlights

Filters